Ciprofoxacin-metronidazole antibiotic composition
US6632453B2 · kind B2 · utility
16Cited by
33References
66Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2002 |
| Grant date | Oct 14, 2003 |
| Priority date | — |
| Expiry date | Mar 18, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/5047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antibiotic product for delivering at least Ciprofoxacin or Metronidazole that is comprised of three dosage forms with different release profiles with each of Ciprofoxacin and Metronidazole being present in at least one of the dosage forms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.